Outpatient Addiction Recovery Services in Aliquippa, PA

About This Facility

Directory information from SAMHSA N-SUMHSS 2025. This listing is not an endorsement or independent verification. Confirm current services, eligibility, and availability directly with the facility.

Services Listed in the Directory

  • Acamprosate (Campral®)

  • Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

  • Adults

    Facility accepts adults (26-64) for treatment.

  • In-network prescribing entity

  • No formal relationship with prescribing entity

  • Buprenorphine (extended-release, injectable)

    An injection used to treat moderate to severe opioid use disorder. This is for adults who received a prescribed or illegal oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for a minimum of 7 days.

  • Buprenorphine used in Treatment

    Buprenorphine is used in medication-assisted treatment (MAT) to help people reduce or quit their use of heroin or other opiates.

  • Buprenorphine maintenance

  • Buprenorphine with naloxone

    A prescription medication that combines buprenorphine (which helps relieve symptoms of opiate withdrawal) and naloxone (reverse the effects of narcotics) used to treat opioid addiction.

  • Buprenorphine without naloxone

    An opioid used to treat opioid addiction by relieving the symptoms of withdrawal. It can be used under the tongue, by injection, as a skin patch, or as an implant.

  • Cash or self-payment

    Payment for treatment is made by the person directly, through cash or other means, rather than using health insurance.

  • Comprehensive substance use assessment

  • Drug and alcohol oral fluid testing

  • Drug or alcohol urine screening

    Analyzes your urine for the presence of certain illegal drugs and prescription medications.

  • Drug Enforcement Agency (DEA)

  • Female

    Female

  • Male

    Male

  • Medicare

    The federal health insurance program for people age 65 and older and people with disabilities.

  • Medicaid

    A joint federal and state program that helps with medical costs for some people with low incomes and limited resources. Medicaid programs vary from state to state.

  • Complete medical history/physical exam

  • Accepts clients using MAT but prescribed elsewhere

  • Naloxone and overdose education

  • Nicotine replacement

    Administers nicotine to the body by means other than tobacco, without other harmful chemicals found in tobacco. Common forms of nicotine replacement therapy are nicotine patches, nicotine gum or lozenges, nasal spray and inhaler. The goal of nicotine replacement is to prevent cravings in a tobacco user, allowing the person to abstain from tobacco.

  • Naltrexone used in Treatment

  • Naltrexone (oral)

  • Outpatient methadone/buprenorphine or naltrexone treatment

  • Outpatient

    Describes patients who receive treatment services without an overnight stay at a treatment facility or hospital.

  • No formal relationship with prescribing entity

  • Private health insurance

  • This facility administers/prescribes medication for alcohol use disorder

  • Private for-profit organization

    A business or other organization whose primary goal is making money (a profit).

  • Relapse prevention with naltrexone

    Program or group specifically tailored for relapse prevention from Naltrexone which helps people retrain their minds and behaviors to avoid alcohol as a solution to emotional or psychological triggers.

  • Substance use treatment

    Refers to a range of services, including problem identification and diagnosis, brief interventions, assessment of substance use and related problems, treatment planning, counseling, medical services, psychiatric services, psychological services, social services, and follow-up for persons with alcohol or other drug problems (Institute of Medicine, 1990).

  • Substance use disorder education

  • Smoking permitted in designated area

    A designated area in which smoking is permitted.

  • Screening for substance use

    Test to determine whether a person is experiencing symptoms of substance use and needs treatment.

  • Screening for tobacco use

    Determines a client's use of tobacco products, such as cigarettes, cigars, pipe tobacco, or smokeless tobacco. It is generally recommended that providers screen for tobacco use on a regular basis by asking clients, as they are seen, about their current and past use of tobacco products and their exposure to secondhand smoke or tobacco.

  • Smoking/vaping/tobacco cessation counseling

    Includes interventions for persons who use tobacco and want help with stopping, including behavioral support or counseling in groups or individually.

  • Telemedicine/telehealth therapy

    The ability for healthcare providers, working remotely and using telecommunications technology, to communicate with patients, diagnose conditions, provide treatment, and discuss healthcare issues with other providers to ensure quality healthcare services are provided.

  • Federal military insurance (e.g., TRICARE)

  • Prescribes buprenorphine

  • Prescribes naltrexone

  • Vaping permitted in designated area

  • Naltrexone (extended-release, injectable)

  • Young Adults

    Facility accepts young adults (18-25) for treatment.

Contact and Location

2360 Hospital Drive, Lower Level, Aliquippa, PA, 15001

Phone: 724-912-6277 x1